Ipamorelin: What the Research Shows

Research Use Only: This article summarises published scientific literature for laboratory and research audiences. It is not medical advice, and Ipamorelin is not approved for human or veterinary use.

What is Ipamorelin?

Ipamorelin is a synthetic pentapeptide studied in the research literature as a selective agonist of the ghrelin receptor (GHSR), placing it in the growth-hormone secretagogue category. It is noted in the literature for its selectivity compared with some earlier secretagogues.

Where Ipamorelin sits in the research literature

The evidence base is largely preclinical, focused on how the peptide affects the growth-hormone axis in laboratory models. In the original characterisation it was reported as the first GHRP-receptor agonist with selectivity for growth-hormone release comparable to GHRH.

Reported areas of preclinical interest

• GHSR agonism: studied as a selective ghrelin-receptor agonist in laboratory models.
• Growth-hormone axis: examined for pulse-like effects on growth-hormone signalling.

Why the “research use only” label matters

Ipamorelin is not approved as a medicinal product and growth-hormone secretagogues are prohibited in competitive sport. It is supplied strictly for laboratory and scientific research and is not for human or veterinary consumption.

Handling and storage

Store lyophilised peptide cool, dry and away from light, and refrigerate reconstituted solution, using it within the indicated stability window. Follow the documentation supplied with each batch.

Frequently asked questions

What does Ipamorelin do in research?

It is studied as a selective ghrelin-receptor agonist that acts on the growth-hormone axis in laboratory models.

Is Ipamorelin approved for human use?

No. It is a research material only, is not intended for human or veterinary use, and is banned in sport.

Key takeaways

Ipamorelin is a selective GHSR agonist studied in growth-hormone-axis research. It is a research material only. Review the Ipamorelin research product, or the Ipamorelin / CJC-1295 mix.

References

References sourced via PubMed.

1. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. DOI · PubMed 9849822.
2. Aagaard NK, Grøfte T, Greisen J, et al. Growth hormone and growth hormone secretagogue effects on nitrogen balance and urea synthesis in steroid treated rats. Growth Horm IGF Res. 2009;19(5):426-431. DOI · PubMed 19231263.

Disclaimer: This article is for informational and educational purposes for a research audience. It is not medical advice. Products referenced are sold strictly for laboratory research and are not for human or veterinary use.